Rezultati pretrage - Mansaray, Rahmatu
- Prikaz rezultata 1 – 4 od 4
-
1
Intrathecal administration of tumor-infiltrating lymphocytes is well tolerated in a patient with leptomeningeal disease from metastatic melanoma: A case report od Glitza, Isabella C., Haymaker, Cara, Bernatchez, Chantale, Vence, Luis, Rohlfs, Michelle, Richard, Jessie, Lacey, Carol, Mansaray, Rahmatu, Fulbright, Orenthial J., Ramachandran, Renjith, Toth, Christopher, Wardell, Seth, Patel, Sapna P., Woodman, Scott E., Hwu, Wen-Jen, Radvanyi, Laszlo G., Davies, Michael A., Papadopoulos, Nicholas E., Hwu, Patrick
Izdano 2015Tekst -
2
Utilizing T-cell activation signals 1, 2 and 3 for tumor-infiltrating lymphocytes (TIL) expansion: the advantage over the sole use of interleukin-2 in cutaneous and uveal melanoma od Tavera, René J., Forget, Marie-Andrée, Kim, Young Uk, Sakellariou-Thompson, Donastas, Creasy, Caitlin A., Bhatta, Ankit, Fulbright, Orenthial J., Ramachandran, Renjith, Thorsen, Shawne T., Flores, Esteban, Wahl, Arely, Gonzalez, Audrey M., Toth, Christopher, Wardell, Seth, Mansaray, Rahmatu, Radvanyi, Laszlo G., Gombos, Dan S., Patel, Sapna P., Hwu, Patrick, Amaria, Rodabe N., Bernatchez, Chantale, Haymaker, Cara
Izdano 2018Tekst -
3
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients od Radvanyi, Laszlo G., Bernatchez, Chantale, Zhang, Minying, Fox, Patricia S., Miller, Priscilla, Chacon, Jessica, Wu, Richard, Lizee, Gregory, Mahoney, Sandy, Alvarado, Gladys, Glass, Michelle, Johnson, Valen E., McMannis, John D., Shpall, Elizabeth, Prieto, Victor, Papadopoulos, Nicholas, Kim, Kevin, Homsi, Jade, Bedikian, Agop, Hwu, Wen-Jen, Patel, Sapna, Ross, Merrick I., Lee, Jeffrey E., Gershenwald, Jeffrey E., Lucci, Anthony, Royal, Richard, Cormier, Janice N., Davies, Michael A., Mansaray, Rahmatu, Fulbright, Orenthial J., Toth, Christopher, Ramachandran, Renjith, Wardell, Seth, Gonzalez, Audrey, Hwu, Patrick
Izdano 2012Tekst -
4
Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome od Forget, Marie-Andrée, Haymaker, Cara, Hess, Kenneth R., Meng, Yuzhong Jeff, Creasy, Caitlin, Karpinets, Tatiana, Fulbright, Orenthial J., Roszik, Jason, Woodman, Scott E., Kim, Young Uk, Sakellariou-Thompson, Donastas, Bhatta, Ankit, Wahl, Arely, Flores, Esteban, Thorsen, Shawne T., Tavera, René J., Ramachandran, Renjith, Gonzalez, Audrey M., Toth, Christopher L., Wardell, Seth, Mansaray, Rahmatu, Patel, Vruti, Carpio, Destiny Joy, Vaughn, Carol, Farinas, Chantell M., Velasquez, Portia G., Hwu, Wen-Jen, Patel, Sapna P., Davies, Michael A., Diab, Adi, Glitza, Isabella C., Tawbi, Hussein, Wong, Michael K., Cain, Suzanne, Ross, Merrick I., Lee, Jeffrey E., Gershenwald, Jeffrey E., Lucci, Anthony, Royal, Richard, Cormier, Janice N., Wargo, Jennifer A., Radvanyi, Laszlo G., Torres-Cabala, Carlos A., Beroukhim, Rameen, Hwu, Patrick, Amaria, Rodabe N., Bernatchez, Chantale
Izdano 2018Tekst